Elevated IL ‐4 and IL ‐13 Expression in Hailey‐Hailey Disease: Evidence for Th2‐Mediated Pathogenesis and Targeted Treatment
Journal of Cutaneous Pathology · 2026-12 · 53 (12) · 1165-1171
DOI: 10.1111/cup.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, online erschienen am 06.07.2026. Verfasst von Simonetta I Gaumond und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Interleukin-13, Pemphigus, Benign Familial, Interleukin-4, Th2 Cells. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Hailey‐Hailey disease (HHD) is a rare autosomal dominant blistering disorder caused by mutations in the ATP2C1 gene, which impair keratinocyte adhesion through disrupted calcium signaling. While traditionally considered a structural defect, recent studies suggest that Th2‐mediated inflammation may exacerbate disease pathology. Interleukin (IL)‐4 and IL‐13, central mediators of type 2 inflammation, have been implicated in barrier dysfunction in other dermatoses, yet their role in HHD remains poorly defined.
Methods
This retrospective study employed immunohistochemistry to assess IL‐4 and IL‐13 expression in lesional skin from patients with HHD ( n = 7) compared to age‐, sex‐, and site‐matched atopic dermatitis (AD) controls ( n = 6) and healthy control samples ( n = 4).
Results
IL‐4 expression was significantly elevated in the epidermis of HHD compared to negative control tissue (mean 3966 cells/mm 2 vs. 808 cells/mm 2 , p = 0.0219), whereas IL‐13 expression was markedly increased in the dermis (mean 5288 cells/mm 2 vs. 629 cells/mm 2 , p < 0.0001), relative to healthy controls. No statistically significant difference was observed between AD and HHD samples.
Conclusions
These findings highlight a potential role for IL‐4 and IL‐13 in the pathogenesis of HHD, supporting the therapeutic relevance for targeting type 2 cytokines. Agents such as dupilumab and potentially JAK inhibitors may offer new avenues for effective disease management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Unit of Clinic Dermatology, Vita-Salute San Raffaele University, Milan, Italy.
- St John's Institute of Dermatology, King's College London, London, UK.
ORCID-Profile: Simonetta I Gaumond, Victoria Soto, Beatriz Abdo Abujamra, Franco Rongioletti, John A McGrath, Ivan Jozic, Paolo Romanelli
Zitieren
APA
Gaumond, S. I., Soto, V., Abujamra, B. A., Rongioletti, F., McGrath, J. A., Jozic, I., & Romanelli, P. (2026). Elevated IL ‐4 and IL ‐13 Expression in Hailey‐Hailey Disease: Evidence for Th2‐Mediated Pathogenesis and Targeted Treatment. Journal of Cutaneous Pathology, 53(12), 1165-1171. https://doi.org/10.1111/cup.70156
Vancouver
Gaumond SI, Soto V, Abujamra BA, Rongioletti F, McGrath JA, Jozic I, et al. Elevated IL ‐4 and IL ‐13 Expression in Hailey‐Hailey Disease: Evidence for Th2‐Mediated Pathogenesis and Targeted Treatment. Journal of Cutaneous Pathology. 2026;53(12):1165-1171. doi:10.1111/cup.70156
BibTeX
@article{Gaumond2026,
author = {Gaumond, Simonetta I and Soto, Victoria and Abujamra, Beatriz Abdo and Rongioletti, Franco and McGrath, John A and Jozic, Ivan and Romanelli, Paolo},
title = {Elevated IL ‐4 and IL ‐13 Expression in Hailey‐Hailey Disease: Evidence for Th2‐Mediated Pathogenesis and Targeted Treatment},
journal = {Journal of Cutaneous Pathology},
year = {2026},
volume = {53},
number = {12},
pages = {1165--1171},
doi = {10.1111/cup.70156}
}
EUVIMED